A kind of traditional Chinese medicine for treating rheumatism and preparation method thereof

Abstract

The invention belongs to a traditional Chinese medicine for treating rheumatism and a preparation method of the traditional Chinese medicine. The traditional Chinese medicine is prepared from the following raw materials in parts by weight: 10-20 parts of cortex phellodendri, 5-15 parts of rhizoma atractylodis, 10-20 parts of radix achyranthis bidentatae, 15-25 parts of semen coicis, 10-20 parts of eucommia ulmoides, 10-20 parts of yam rhizome, 10-20 parts of radix clematidis, 15-25 parts of corn stigma, 15-25 parts of pleione bulbocodioides, 20-40 parts of rhizoma smilacis glabrae, 10-20 parts of poria cocos, 10-20 parts of polygonum cuspidatum, 5-10 parts of olibanum, 8-15 parts of peach kernel, 5-10 parts of myrrh, 10-20 parts of fritillary bulb, 4-10 parts of radix notoginseng powder, 10-20 parts of longspur epimedium, 10-15 parts of safflower, 6-12 parts of lycopus lucidus, 6-12 parts of rhizoma alismatis, 10-20 parts of pine nodular branch and 10-15 parts of lumbricus. All the raw materials are reasonable in compatibility. The traditional Chinese medicine has the effects of detoxifying, expelling heat, expelling dampness, diminishing inflammation and relieving pain and takes remarkably effect on the common fever, redness and swelling of joints, numbness of limb and aching pain.

Description

technical field [0001] The invention belongs to the field of medicines, and in particular relates to a traditional Chinese medicine for treating rheumatism with various Chinese medicinal materials as raw materials and a preparation method thereof. Background technique [0002] Rheumatism is a group of diseases mainly invading joints, bones, muscles, blood vessels and related soft or connective tissues, most of which are autoimmune diseases. The onset is mostly hidden and slow, the course of the disease is long, and most of them have genetic predisposition. Diagnosis and treatment are difficult. Different autoantibodies can be detected in the blood, which may be related to different HLA subtypes. It has a good short-term response to non-steroidal anti-inflammatory drugs (NSAIDs), glucocorticoids and immunosuppressants. or long-term remission. In a broad sense, it is believed that all diseases that cause bone, joint and muscle pain can be classified as rheumatism. So far, i...

AI Technical Summary

Problems solved by technology

And drug therapy mainly uses non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, disease-modifying antirheumatic drugs (DMARDs). The liver, kidney, bladder, lung, gastrointestinal tract, gonad, and tissue bone marrow all have different toxic effects, and long-term use will have a greater impact on human health. In addition, patients treated with these drugs are prone to drug development Once the drug is stopped, the condition will recover or even become more serious, which will bring greater pain to the patient and increase the cost of treating the disease